IPD vs NYR

ASX Healthcare sector comparison — updated 23 Jul 2026 — Healthcare sector

IPD

IMPEDIMED FPO [IPD]

51MEDIUM

NYR

NYRADA CDI FORUS [NYR]

51MEDIUM

Score Breakdown

IPD NYR
Technical
51
49
Catalyst
53
52
Sentiment
50
50
Fundamental
85
34
Momentum
30
75
Risk Gate
27
42

Key Metrics

IPD Metric NYR
$18.3MMarket Cap$135.9M
6.1MAvg Volume (20d)326K
N/AShort InterestN/A
$0.05952-Week High$1.435
$0.00552-Week Low$0.225
+0.0%Daily Change-6.1%
$0.005Reference Price$0.535
-117.9%ROE-71.0%
-171.3%Profit Margin-234.3%

Active Signals

IPD Signals

RSI drifting toward oversold territory — worth watching
Stochastic is deep in oversold territory — bounce conditions forming
Trading below both moving averages — the trend is working against this one
Volume surging at 4.1x normal while price falls — heavy selling pressure
Sitting near support — this level has held before and could attract buyers again
Took a hit — down 16.7% over the last 5 days
Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
Volatility is contracting — like a spring being compressed, breakouts often follow

NYR Signals

Stochastic turning bearish from a high level — caution
Golden cross just fired — the short-term trend is overtaking the long-term, which is classically bullish
Volume surging at 2.2x normal while price falls — heavy selling pressure
Beating the Small Ords index — relative strength of 1.27, so it's outpacing the pack
Below the 200-day average — the long-term trend is still working against it
Low cash runway (4 quarters) - dilution risk
Very high P/S ratio (57.1x)
Piotroski F-Score weak (3/9, low-confidence approx)

Ask Scout AI to compare IPD and NYR in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

CBL vs NYR →ACL vs NYR →IPD vs LGP →CBL vs LGP →ACL vs LGP →
IPD Full Analysis → NYR Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).